A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body
Clinical trial NCT03241264 · COMPLETED
Trial details
- NCT number
- NCT03241264
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-28
- Primary completion
- 2016-10-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.